Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Summary
This trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.
Official title: A Randomized, Double-blind, Placebo-controlled Phase IIa Study to Evaluate the Efficacy and Safety of SHR-1905 Injection in Patients With Moderate to Severe Atopic Dermatitis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2025-11-07
Completion Date
2027-02
Last Updated
2026-04-08
Healthy Volunteers
No
Conditions
Interventions
SHR-1905 Injection
SHR-1905 injection.
SHR-1905 Injection Blank Preparation
SHR-1905 injection blank preparation.
Locations (1)
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China